Table 1 Demographics and vaccination status of patients
From: Impact of vaccination status on clinical outcomes of hospitalized COVID-19 patients
General Data | Overall (N = 615) |
|---|---|
Sex, N (%) | Â |
Male | 280(45.5) |
Female | 335(54.5) |
BMI, N (%) | Â |
< 30 | 425(69.1) |
> 30 | 190(30.9) |
Comorbidities, N (%) | Â |
Hypertension | 243(39.5) |
Diabetes Mellitus | 188(30.6) |
Dyslipidemia | 143(23.3) |
Ischemic Heart Disease | 97(15.8) |
Chronic kidney disease | 77(12.5) |
Hypothyroidism | 40(6.5) |
Chronic Obstructive Pulmonary Disease | 26(4.2) |
Cancer | 13(2.1) |
Cerebrovascular accident | 11(1.8) |
Imaging Result at Baseline | Â |
Score of lung involvement at baseline, N (%) | Â |
0–8 | 439(71.4) |
9–16 | 144(23.4) |
17–25 | 32(5.2) |
Vaccination Status, N (%) | Â |
no vaccine | 203(33) |
Partial vaccination | 127(20.65) |
Complete vaccination | 285(46.35) |
Vaccine type, N (%) | Â |
Inactive | 341(55.44) |
viral vector | 52(8.5) |
Recombinant proteins | 3(0.5) |
Recombinant proteins + inactive | 12(2) |
viral vector + inactive | 4(0.7) |
Intubation, N (%) | 67(10.9) |
Death, N (%) | 82(13.3) |